This study has undergone independent external review as part of the King’s Research and Development protocol, and has been approved by the London – Dulwich Research Ethics Committee.

This study is sponsored by King’s College Hospital NHS Foundation Trust and funded by Hologic Inc. Hologic are the first manufacturers to develop this 3D tomosynthesis technique that is accepted for use in the NHS breast screening program.